Company

CCORE is a medical technology firm that is committed to research and developmentist of minimally invasive, intracorporeal blood-purification technologies.

Our approach to blood purification is designed to complement traditional extracorporeal technologies as well as provide alternatives for patients with acute or chronic organ dysfunction.

CCORE was founded in 2016 by Claus G. Krenn and Roman Ullrich, intensive care specialists at the Medical University of Vienna.

Having worked for many years in intensive care, they had in-depth knowledge of the challenges of extracorporeal blood purification. Messrs Krenn and Ullrich founded CCORE with the aim of advancing and improving these systems. Our mission is therefore to develop and bring to market innovative methods of minimally invasive blood purification.

By partnering with both academic and commercial scientists, we are able to maximize the probability of project success.By partnering with both academic and commercial scientists, we are able to maximize the probability of project success. We are also fortunate to have a highly qualified internal team of experienced engineers and clinical scientists.

 

CCORE is a medical technology firm that is committed to research and development
of minimally invasive, intracorporeal blood-purification technologies.

Our approach to blood purification is designed to complement traditional extracorporeal technologies as well as provide alternatives for patients with acute or chronic organ dysfunction.

CCORE was founded in 2016 by Claus G. Krenn and Roman Ullrich, intensive care specialists at the Medical University of Vienna.

Team Stimmung 2

Having worked for many years in intensive care, they had in-depth knowledge of the challenges of extracorporeal blood purification. Messrs Krenn and Ullrich founded CCORE with the aim of advancing and improving these systems.

Our mission is therefore to develop and bring to market innovative methods of minimally invasive blood purification.
By partnering with both academic and commercial scientists, we are able to maximize the probability of project success.
We are also fortunate to have a highly qualified internal team of experienced engineers and clinical scientists.